Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-250
Closed -$17.9K 454
2023
Q4
$17.9K Hold
250
﹤0.01% 336
2023
Q3
$17.4K Hold
250
﹤0.01% 327
2023
Q2
$20.2K Buy
250
+40
+19% +$3.27K ﹤0.01% 302
2023
Q1
$16.9K Sell
210
-4
-2% -$322 ﹤0.01% 334
2022
Q4
$16K Buy
214
+60
+39% +$4.27K ﹤0.01% 389
2022
Q3
$10K Sell
154
-81
-34% -$5.61K ﹤0.01% 432
2022
Q2
$16K Sell
235
-18
-7% -$1.34K ﹤0.01% 370
2022
Q1
$20K Buy
253
+203
+406% +$14.6K ﹤0.01% 341
2021
Q4
$4K Buy
50
+26
+108% +$1.91K ﹤0.01% 624
2021
Q3
$2K Buy
+24
New +$1.8K ﹤0.01% 619
2017
Q3
Sell
-185
Closed -$8K 499
2017
Q2
$8K Hold
185
﹤0.01% 355
2017
Q1
$8K Hold
185
﹤0.01% 308
2016
Q4
$7K Buy
+185
New +$7.14K ﹤0.01% 342

Other funds holding HOLX

Lee Financial's HOLX Position: Q1 2024 in Review

Lee Financial sold out of Hologic (HOLX) in Q1 2024, closing a stake of 250 shares — an estimated $17.9K sold.

Lee Financial first reported a position in HOLX in Q4 2016 and held it in 13 quarters. The position peaked at $20.2K in Q2 2023. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Lee Financial reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 250 Hologic shares in Q1 2024, an estimated $17.9K.
  • Lee Financial first reported a position in Hologic in Q4 2016 and held it in 13 quarters.
  • Lee Financial's Hologic position peaked at $20.2K in Q2 2023.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.